Vanguard Group
NMRD

Vanguard Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Vanguard Group’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-126,682
Closed -$27.7K – 4550
2023
Q4 		$27.7K Hold
126,682
– – ﹤0.01% 4423
2023
Q3 		$39.9K Sell
126,682
-4,179
-3% -$2.9K ﹤0.01% 4437
2023
Q2 		$121K Hold
130,861
– – ﹤0.01% 4373
2023
Q1 		$117K Hold
130,861
– – ﹤0.01% 4389
2022
Q4 		$225K Buy
130,861
+285
+0.2% +$629 ﹤0.01% 4292
2022
Q3 		$272K Hold
130,576
– – ﹤0.01% 4367
2022
Q2 		$336K Hold
130,576
– – ﹤0.01% 4377
2022
Q1 		$570K Sell
130,576
-1,935
-1% -$8.09K ﹤0.01% 4370
2021
Q4 		$604K Sell
132,511
-548
-0.4% -$2.95K ﹤0.01% 4395
2021
Q3 		$800K Buy
133,059
+807
+0.6% +$5.81K ﹤0.01% 4295
2021
Q2 		$1.37M Sell
132,252
-26,729
-17% -$255K ﹤0.01% 4076
2021
Q1 		$1.22M Buy
158,981
+13,636
+9% +$90.3K ﹤0.01% 3971
2020
Q4 		$549K Buy
145,345
+2,986
+2% +$11.5K ﹤0.01% 3939
2020
Q3 		$505K Sell
142,359
-23,150
-14% -$135K ﹤0.01% 3817
2020
Q2 		$1.53M Buy
+165,509
New +$1.18M ﹤0.01% 3509

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Vanguard Group's NMRD Position: Q1 2024 in Review

Vanguard Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 126,682 shares — an estimated $27.7K sold.

Vanguard Group first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $1.53M in Q2 2020. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Vanguard Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Vanguard Group sold 126,682 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $27.7K.
  • Vanguard Group first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Vanguard Group's Nemaura Medical, Inc. Common Stock position peaked at $1.53M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.